Clinical Research

As a pioneer in cardiovascular care, we remain at the forefront of cardiovascular research. 

Notable accomplishments

In 2024, we led the charge with participation in over 200 active clinical trials, ranking among the top five global enrollers in many trials. This exceptional commitment to research solidifies our position as a leader in cardiovascular advancements. Our extensive clinical research portfolio, coupled with a team of seasoned experts, drives advancements in innovations and care.

“From our inception, Baylor Scott & White The Heart Hospital was built on delivering cutting-edge cardiac care and propelling medical knowledge forward through clinical trials. We remain at the forefront of sharing our expertise through international presentations, publications and education. This dedication rings true today.”

J. Michael DiMaio, MD

Chief of Staff
Medical Director, Graduate and Post-Graduate Training and Publications  


Molly Szerlip, MD

Associate Medical Director, Education And Research

Increase in external grants for investigator-initiated projects

Our researchers received grant support of $3.4 million for 18 studies in 2024 across all of our service lines. These funds from the Foundation and Research Institute have been augmented by $1.7 million of industry support.

Of note, Paul Grayburn, MD, and colleagues received funds to further research mitral valve regurgitation via the CAROL Act grant. This grant was awarded to fund some of the infrastructure for the Cardiothoracic Surgical Trials Network (CSTN). CSTN provides a platform to collaborate with investigators and the National Heart, Lung, and Blood Institute to design, conduct and analyze impactful clinical trials of surgical interventions, as well as to undertake mechanistic studies and implementation science in the area of cardiovascular disease.

Explore our research initiatives

Driving the field of cardiovascular care forward

Previous

Next